Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Operating Expenses: 2020-2025

Historic Operating Expenses for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $86,725.

  • Cellebrite DI's Operating Expenses fell 99.88% to $86,725 in Q3 2025 from the same period last year, while for Sep 2025 it was $321,396, marking a year-over-year decrease of 99.88%. This contributed to the annual value of $281,704 for FY2024, which is 99.88% down from last year.
  • Per Cellebrite DI's latest filing, its Operating Expenses stood at $86,725 for Q3 2025, which was up 6.83% from $81,182 recorded in Q2 2025.
  • Cellebrite DI's Operating Expenses' 5-year high stood at $72.0 million during Q3 2024, with a 5-year trough of $75,698 in Q4 2024.
  • Over the past 3 years, Cellebrite DI's median Operating Expenses value was $58.7 million (recorded in 2023), while the average stood at $40.5 million.
  • As far as peak fluctuations go, Cellebrite DI's Operating Expenses surged by 64.07% in 2021, and later crashed by 99.88% in 2025.
  • Cellebrite DI's Operating Expenses (Quarterly) stood at $51.3 million in 2021, then climbed by 1.85% to $52.2 million in 2022, then rose by 20.85% to $63.1 million in 2023, then crashed by 99.88% to $75,698 in 2024, then plummeted by 99.88% to $86,725 in 2025.
  • Its last three reported values are $86,725 in Q3 2025, $81,182 for Q2 2025, and $77,791 during Q1 2025.